Worapol Ngamcherdtrakul

Principal Scientist and Chief Operating Officer
PDX Pharmaceuticals
Mehrdad Kheiripour
Dr. Ngamcherdtrakul joined PDX Pharmaceuticals in 2015. He received his PhD in Biomedical Engineering from Oregon Health & Science University. The focus of his PhD dissertation was to develop a mesoporous silica nanoparticle into a carrier for siRNA delivery to treat breast cancer. At PDX Pharma, he leads the design, development, and optimization of nanoparticle platform to co-deliver drug, siRNA, and immunotherapy for treatment of multiple types of cancer and skin diseases. He is the contact PI of PDX Pharma’s ongoing SBIR grants from the National Institute of Health.


No data was found